Search
Learn about MSK's specialty in treating neuroendocrine cancers.
A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.
For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue.
Learn how Kéara was able to maintain her quality of life after treatment for triple negative breast cancer.
Scientists are learning how tumors develop resistance to drugs — and what can be done about it.
Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.
MSK researchers are helping to map the landscape of viruses that infect us all, and to analyze the impact they have on human health and disease.
Spend a day with the expert team in MSK's world-renowned sarcoma service.
Michelle Smith-Levitin was facing the devastating possibility of having her leg amputated when she sought a second opinion at MSK.
In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.